Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection

NACompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

June 30, 2023

Conditions

Genitourinary; Infection, Complicating Pregnancy

Interventions

DIETARY_SUPPLEMENT

Probiotic iNatal®

iNatal® (Enterococcus faecium L3, Bifidobacterium animalis subsp. lactis BB-12, Lactococcus lactis SP38, Lacticaseibacillus casei R0215)

Trial Locations (1)

Department of Obstetrics and Gynecology PERUGIA HOSPITAL, Perugia

All Listed Sponsors

collaborator

Università degli Studi dell'Insubria

OTHER

lead

Liaquat University of Medical & Health Sciences

OTHER

NCT06231056 - Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection | Biotech Hunter | Biotech Hunter